BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2021 2:11:51 AM | Browse: 430 | Download: 1108
 |
Received |
|
2021-03-02 07:52 |
|
Peer-Review Started |
|
2021-03-02 07:58 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-03 23:33 |
|
Revised |
|
2021-07-03 14:24 |
|
Second Decision |
|
2021-07-12 03:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-07-12 09:00 |
|
Articles in Press |
|
2021-07-12 09:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-27 19:35 |
|
Typeset the Manuscript |
|
2021-08-10 06:42 |
|
Publish the Manuscript Online |
|
2021-08-25 02:11 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Microbiology |
| Manuscript Type |
Minireviews |
| Article Title |
Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yong-Bo Kang and Yue Cai |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Science Research Start-up Fund for Doctor of Shanxi Medical University |
XD180 |
| Science Research Start-up Fund for Doctor of Shanxi Province |
SD1807 |
| Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi |
2019L0425 |
| Shanxi Province Science Foundation for Youths |
201901D211314 |
|
| Corresponding Author |
Yong-Bo Kang, PhD, Associate Professor, Department of Microbiology and Immunology, School of Basic Medical Sciences, Shanxi Medical University, Zhongdu Campus, Yuci District, Jinzhong 030600, Shanxi Province, China. 657151276@qq.com |
| Key Words |
Gut microbiome; Immunotherapy; Programmed cell death protein 1/programmed cell death protein ligand 1; Cytotoxic T-lymphocyte-associated protein 4; Immune checkpoint inhibitors resistance; Faecal microbiota transplantion |
| Core Tip |
Gut microbiota composition is closely associated with the efficacy of immune checkpoint inhibitors (ICIs). Specific species among the intestinal commensal bacteria may play a key role in the efficacy of ICIs against cancer. Faecal microbiota transplantation may enhance efficacy of ICIs. |
| Publish Date |
2021-08-25 02:11 |
| Citation |
Kang YB, Cai Y. Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer. World J Gastroenterol 2021; 27(32): 5362-5375 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i32/5362.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i32.5362 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
